Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline

Diagnostic Microbiology and Infectious Disease

Volumn 88, Issue 4, 2017, Pages 365-367

  Chen, Alice ^a   Smith, Kenneth P ^b   Whitfield, Betsy A ^a   Zucchi, Paola C ^a   Lasco, Todd M ^c   Bias, Tiffany E ^d,e   Kirby, James E ^b,f   Hirsch, Elizabeth B ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c CHI ST LUKE S HEALTH BAYLOR ST LUKE S MEDICAL CENTER   (United States)

^d HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Extended spectrum beta lactamase; KPC; Multidrug resistance; Resistant; Tetracycline

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; GEOGRAPHY; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; ANALOGS AND DERIVATIVES; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DOXYCYCLINE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 85019900749     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2017.05.004     Document Type: Article

References (29)

1. Alexander, B.T., Marschall, J., Tibbetts, R.J., Neuner, E.A., Dunne, W.M. Jr., Ritchie, D.J., Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort. Clin Ther 34 (2012), 1314–1323, 10.1016/j.clinthera.2012.05.002.
2. Castanheira, M., Mills, J.C., Costello, S.E., Jones, R.N., Sader, H.S., Ceftazidime-avibactam activity tested against Enterobacteriaceae from United States hospitals (2011-2013) and characterization of beta-lactamase producing strains. Antimicrob Agents Chemother, 2015, 10.1128/AAC.00163-15.
3. Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing; twenty-seventh informational supplement. M100-S27, 2017 [Wayne, PA].
4. Colton, B., McConeghy, K.W., Schreckenberger, P.C., Danziger, L.H., I.V. Minocycline revisited for infections caused by multidrug-resistant organisms. Am J Health Syst Pharm 73 (2016), 279–285, 10.2146/ajhp150290.
5. Denys, G.A., Callister, S.M., Dowzicky, M.J., Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline evaluation and surveillance trial (T.E.S.T.). Ann Clin Microbiol Antimicrob, 12, 2013, 24, 10.1186/1476–0711–12-24.
6. Deshpande, L.M., Doyle, T., Castanheira, M., GenBank. Available at https://www.ncbi.nlm.nih.gov/nuccore/961438186, 2015 [Last accessed April 27, 2017].
7. Endimiani, A., Hujer, A.M., Perez, F., Bethel, C.R., Hujer, K.M., Kroeger, J., et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the eastern USA. J Antimicrob Chemother 63 (2009), 427–437, 10.1093/jac/dkn547 [dkn547 [pii]].
8. Goff, D.A., Kaye, K.S., Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 59:Suppl. 6 (2014), S365–S366, 10.1093/cid/ciu531.
9. Hirsch, E.B., Chang, K.T., Lasco, T.M., Caeiro, J.P., Tam, V.H., Emergence of KPC-producing Klebsiella pneumoniae in Texas. Diagn Microbiol Infect Dis 69 (2011), 234–235, 10.1016/j.diagmicrobio.2010.09.003 [S0732–8893(10)00363–9 pii].
10. Hirsch, E.B., Guo, B., Chang, K.T., Cao, H., Ledesma, K.R., Singh, M., et al. Assessment of antimicrobial combinations for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae. J Infect Dis, 2013, 10.1093/infdis/jis766 [jis766 [pii]].
11. Hirsch, E.B., Tam, V.H., Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65 (2010), 1119–1125, 10.1093/jac/dkq108 [dkq108 [pii]].
12. Idelevich, E.A., Busing, M., Mischnik, A., Kaase, M., Bekeredjian-Ding, I., Becker, K., False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study. J Med Microbiol 65 (2016), 877–881, 10.1099/jmm.0.000281.
13. Liscio, J.L., Mahoney, M.V., Hirsch, E.B., Ceftolozane/tazobactam and ceftazidime/avibactam: two novel beta-lactam/beta-lactamase inhibitor combination agents for the treatment of resistant gram-negative bacterial infections. Int J Antimicrob Agents 46 (2015), 266–271, 10.1016/j.ijantimicag.2015.05.003.
14. Livermore, D.M., Tigecycline: what is it, and where should it be used?. J Antimicrob Chemother 56 (2005), 611–614, 10.1093/jac/dki291.
15. Livermore, D.M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., Woodford, N., What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37 (2011), 415–419, 10.1016/j.ijantimicag.2011.01.012.
16. MacGowan, A.P., Tigecycline pharmacokinetic/pharmacodynamic update. J Antimicrob Chemother 62:Suppl. 1 (2008), i11–i16, 10.1093/jac/dkn242.
17. Pitout, J.D., Nordmann, P., Poirel, L., Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59 (2015), 5873–5884, 10.1128/AAC.01019-15.
18. Pogue, J.M., Neelakanta, A., Mynatt, R.P., Sharma, S., Lephart, P., Kaye, K.S., Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis 59:Suppl. 6 (2014), S388–S393, 10.1093/cid/ciu594.
19. Qureshi, Z.A., Paterson, D.L., Potoski, B.A., Kilayko, M.C., Sandovsky, G., Sordillo, E., et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 56 (2012), 2108–2113, 10.1128/AAC.06268-11AAC.06268-11 [pii].
20. Smith, K.P., Kirby, J.E., Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae. Diagn Microbiol Infect Dis 86 (2016), 439–441, 10.1016/j.diagmicrobio.2016.09.002.
21. Temkin, E., Adler, A., Lerner, A., Carmeli, Y., Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci 1323 (2014), 22–42, 10.1111/nyas.12537.
22. Temkin, E., Torre-Cisneros, J., Beovic, B., Benito, N., Giannella, M., Gilarranz, R., et al. Ceftazidime-avibactam as salvage therapy for infections caused by Carbapenem-resistant organisms. Antimicrob Agents Chemother, 2017, 61, 10.1128/AAC.01964-16.
23. The European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters version 7.1. http://www.eucast.org, 2017.
24. The Medicines Company, Minocin (minocycline) for injection. Prescribing information, 2015 [Parsippany, New Jersey; Available at http://www.minociniv.com/; Last accessed April 27, 2017].
25. Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E.M., Tumietto, F., Marchese, A., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55 (2012), 943–950, 10.1093/cid/cis588.
26. Welling, P.G., Shaw, W.R., Uman, S.J., Tse, F.L., Craig, W.A., Pharmacokinetics of minocycline in renal failure. Antimicrob Agents Chemother 8 (1975), 532–537.
27. Wyeth, T.M., Tygacil product monograph. Available at www.pfizer.ca/sites/g/files/g10017036/f/201410/TYGACIL_PM_E_168980_17Jan2014.pdf, 2014 [Last accessed April 27, 2017].
28. Yigit, H., Queenan, A.M., Anderson, G.J., Domenech-Sanchez, A., Biddle, J.W., Steward, C.D., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother, 52, 2008, 809.
29. Zhang, J., Zhao, C., Chen, H., Wang, X., Li, H., Zhang, Y., et al. Comparative evaluation of tigecycline susceptibility testing methods for Acinetobacter baumannii and Enterobacteriaceae. J Glob Antimicrob Resist 3 (2015), 75–79, 10.1016/j.jgar.2015.02.004.